This segment focuses on developing and commercializing innovative wound care solutions, particularly utilizing placental-derived allografts. Research and development efforts are directed towards enhancing the efficacy and application of these allografts in treating chronic and complex wounds, such as diabetic foot ulcers. The company leverages its patented BioREtain technology and Vendaje product line to promote faster wound closure and improved patient outcomes. Clinical trials are conducted to validate the therapeutic benefits and secure regulatory approvals. Future opportunities include expanding the product portfolio and exploring new applications in burn treatment and surgical wound healing. BioStem partners with Venture Medical, LLC to enhance market reach and distribution.

This segment is dedicated to the discovery, development, and production of regenerative medicine products and services. The company explores various biologic stem cell-based alternative products for treating ailments such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. Research efforts focus on harnessing the natural properties of perinatal tissue to stimulate tissue repair and regeneration. The company aims to develop targeted therapies that address the underlying causes of disease and improve patient quality of life. Future growth potential lies in expanding the range of therapeutic applications and developing personalized regenerative medicine solutions.